This loss of CTCF binding is coincident with a switch in epigenetic mark enrichment, from an active to inactive chromatin state, and with reduced CADM1 expression, but not with increased CpG hypermethylation as has been described in HPV-driven cancers. The gene discussed is CADM1; the disease is cancer.